Dynavax Technologies Corp’s recently made public that its Officer DAVID NOVACK acquired Company’s shares for reported $1.78 million on Jan 15 ’26. In the deal valued at $15.64 per share,114,000 shares were bought.
Then, Novack David F sold 30,000 shares, generating $464,700 in total proceeds. Upon selling the shares at $15.49, the President & COO now owns 111,451 shares.
Before that, DAVID NOVACK bought 30,000 shares. Dynavax Technologies Corp shares valued at $464,700 were divested by the Officer at a price of $15.49 per share.
Goldman downgraded its Dynavax Technologies Corp [DVAX] rating to a Sell from a a Neutral in a research note published on February 11, 2025; the price target was decreased to $12 from $15. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early February with a ‘”a Neutral”‘ rating. JMP Securities began covering DVAX with “Mkt outperform” recommendation on September 27, 2022.
Price Performance Review of DVAX
On Friday, Dynavax Technologies Corp [NASDAQ:DVAX] saw its stock jump 0.06% to $15.63. Over the last five days, the stock has gained 1.43%. Dynavax Technologies Corp shares have risen nearly 25.24% since the year began. Nevertheless, the stocks have risen 1.63% over the past one year.
How much short interest is there in Dynavax Technologies Corp?
A steep rise in short interest was recorded in Dynavax Technologies Corp stocks on 2025-12-31, dropping by -3.67 million shares to a total of 10.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 14.29 million shares. There was a decline of -34.53%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 06, 2021 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $19 price target.
